메뉴 건너뛰기




Volumn 11, Issue 6, 2009, Pages 452-459

Emerging inflammatory markers for assessing coronary heart disease risk

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CD40 LIGAND; DARAPLADIB; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 18; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYELOPEROXIDASE; OMEGA 3 FATTY ACID; PHOSPHOLIPASE A2; PLACEBO; ROSUVASTATIN; SECRETORY PHOSPHOLIPASE A2; VARESPLADIB;

EID: 72849144466     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-009-0065-1     Document Type: Review
Times cited : (19)

References (46)
  • 1
    • 38849091997 scopus 로고    scopus 로고
    • Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
    • DOI 10.1002/sim.2929
    • M.J. Pencina R.B. D'Agostino Sr R.B. D'Agostino Jr R.S. Vasan 2008 Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 157 172 10.1002/sim.2929 17569110 (Pubitemid 351193639)
    • (2008) Statistics in Medicine , vol.27 , Issue.2 , pp. 157-172
    • Pencina, M.J.1    D'Agostino Sr., R.B.2    D'Agostino Jr., R.B.3    Vasan, R.S.4
  • 2
    • 49949092132 scopus 로고    scopus 로고
    • Role of secretory phospholipases in atherogenesis
    • 10.1007/s11883-008-0039-6 18489854
    • A.C. Jönsson-Rylander S. Lundin B. Rosengren, et al. 2008 Role of secretory phospholipases in atherogenesis Curr Atheroscler Rep 10 252 259 10.1007/s11883-008-0039-6 18489854
    • (2008) Curr Atheroscler Rep , vol.10 , pp. 252-259
    • Jönsson-Rylander, A.C.1    Lundin, S.2    Rosengren, B.3
  • 3
    • 33847612773 scopus 로고    scopus 로고
    • Biomarkers of atherosclerotic plaque instability and rupture
    • DOI 10.1161/01.ATV.0000251503.35795.4f, PII 0004360520070100000005
    • W. Koenig N. Khuseyinova 2007 Biomarkers of atherosclerotic plaque instability and rupture Arterioscler Thromb Vasc Biol 27 15 26 10.1161/01.ATV.0000251503.35795.4f 1:CAS:528:DC%2BD28XhtlSrsb7I 17082488 (Pubitemid 46360377)
    • (2007) Arteriosclerosis, Thrombosis, and Vascular Biology , vol.27 , Issue.1 , pp. 15-26
    • Koenig, W.1    Khuseyinova, N.2
  • 4
    • 38749112555 scopus 로고    scopus 로고
    • Inflammation in atherosclerosis: From vascular biology to biomarker discovery and risk prediction
    • DOI 10.1373/clinchem.2007.097360
    • R.R. Packard P. Libby 2008 Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction Clin Chem 54 24 38 10.1373/clinchem.2007.097360 1:CAS:528:DC%2BD1cXmtFelsg%3D%3D 18160725 (Pubitemid 351182593)
    • (2008) Clinical Chemistry , vol.54 , Issue.1 , pp. 24-38
    • Packard, R.R.S.1    Libby, P.2
  • 5
    • 39549093148 scopus 로고    scopus 로고
    • General cardiovascular risk profile for use in primary care: The Framingham heart study
    • DOI 10.1161/CIRCULATIONAHA.107.699579
    • R.B. D'Agostino Sr R.S. Vasan M.J. Pencina, et al. 2008 General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 743 753 10.1161/CIRCULATIONAHA.107.699579 18212285 (Pubitemid 351640675)
    • (2008) Circulation , vol.117 , Issue.6 , pp. 743-753
    • D'Agostino Sr., R.B.1    Vasan, R.S.2    Pencina, M.J.3    Wolf, P.A.4    Cobain, M.5    Massaro, J.M.6    Kannel, W.B.7
  • 6
    • 33846996345 scopus 로고    scopus 로고
    • Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds Risk Score
    • DOI 10.1001/jama.297.6.611
    • P.M. Ridker J.E. Buring N. Rifai N.R. Cook 2007 Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score JAMA 297 611 619 10.1001/jama.297.6.611 1:CAS:528:DC%2BD2sXhslCqtLk%3D 17299196 (Pubitemid 46257283)
    • (2007) Journal of the American Medical Association , vol.297 , Issue.6 , pp. 611-619
    • Ridker, P.M.1    Buring, J.E.2    Rifai, N.3    Cook, N.R.4
  • 7
    • 57749210419 scopus 로고    scopus 로고
    • C-reactive protein and parental history improve global cardiovascular risk prediction: The Reynolds Risk Score for men
    • 10.1161/CIRCULATIONAHA.108.814251 1:CAS:528:DC%2BD1cXhtlyks7bE 18997194
    • P.M. Ridker N.P. Paynter N. Rifai, et al. 2008 C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men Circulation 118 2243 2251 10.1161/CIRCULATIONAHA.108.814251 1:CAS:528:DC%2BD1cXhtlyks7bE 18997194
    • (2008) Circulation , vol.118 , pp. 2243-2251
    • Ridker, P.M.1    Paynter, N.P.2    Rifai, N.3
  • 9
    • 33644868473 scopus 로고    scopus 로고
    • Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age
    • DOI 10.1161/CIRCULATIONAHA.105.548206, PII 0000301720060214000009
    • D.M. Lloyd-Jones E.P. Leip M.G. Larson, et al. 2006 Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age Circulation 113 791 798 10.1161/CIRCULATIONAHA.105.548206 16461820 (Pubitemid 43754299)
    • (2006) Circulation , vol.113 , Issue.6 , pp. 791-798
    • Lloyd-Jones, D.M.1    Leip, E.P.2    Larson, M.G.3    D'Agostino, R.B.4    Beiser, A.5    Wilson, P.W.F.6    Wolf, P.A.7    Levy, D.8
  • 10
    • 37749027640 scopus 로고    scopus 로고
    • CD40/CD40L system and vascular disease
    • 10.1007/s11739-007-0076-0 1:STN:280:DC%2BD1c3psVKkuw%3D%3D 18043876
    • F. Santilli S. Basili P. Ferroni G. Davì 2007 CD40/CD40L system and vascular disease Intern Emerg Med 2 256 268 10.1007/s11739-007-0076-0 1:STN:280:DC%2BD1c3psVKkuw%3D%3D 18043876
    • (2007) Intern Emerg Med , vol.2 , pp. 256-268
    • Santilli, F.1    Basili, S.2    Ferroni, P.3    Davì, G.4
  • 11
    • 56049105881 scopus 로고    scopus 로고
    • Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16
    • 10.1007/s11239-007-0156-z 1:CAS:528:DC%2BD1cXhtlalsL3L 17917707
    • B.A. Olenchock S.D. Wiviott S.A. Murphy, et al. 2008 Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16 J Thromb Thrombolysis 26 79 84 10.1007/s11239-007- 0156-z 1:CAS:528:DC%2BD1cXhtlalsL3L 17917707
    • (2008) J Thromb Thrombolysis , vol.26 , pp. 79-84
    • Olenchock, B.A.1    Wiviott, S.D.2    Murphy, S.A.3
  • 12
    • 54349093968 scopus 로고    scopus 로고
    • Clinical correlates, heritability, and genetic linkage of circulating CD40 ligand in the Framingham Offspring Study
    • 10.1016/j.ahj.2008.06.041 1:CAS:528:DC%2BD1cXht12gtLvP 19061720
    • J.F. Keaney Jr I. Lipinska M.G. Larson, et al. 2008 Clinical correlates, heritability, and genetic linkage of circulating CD40 ligand in the Framingham Offspring Study Am Heart J 156 1003 1009 10.1016/j.ahj.2008.06.041 1:CAS:528:DC%2BD1cXht12gtLvP 19061720
    • (2008) Am Heart J , vol.156 , pp. 1003-1009
    • Keaney Jr, J.F.1    Lipinska, I.2    Larson, M.G.3
  • 13
    • 57649217441 scopus 로고    scopus 로고
    • Interleukin-18 and the risk of future cardiovascular disease among initially healthy women
    • 10.1016/j.atherosclerosis.2008.04.015 1:CAS:528:DC%2BD1cXhsFajsbzJ 18514203
    • B.M. Everett S. Bansal N. Rifai, et al. 2009 Interleukin-18 and the risk of future cardiovascular disease among initially healthy women Atherosclerosis 202 282 288 10.1016/j.atherosclerosis.2008.04.015 1:CAS:528:DC%2BD1cXhsFajsbzJ 18514203
    • (2009) Atherosclerosis , vol.202 , pp. 282-288
    • Everett, B.M.1    Bansal, S.2    Rifai, N.3
  • 14
    • 56149115078 scopus 로고    scopus 로고
    • Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome
    • 10.1097/HJR.0b013e3282f37a6e 18525381
    • C. Espinola-Klein H.J. Rupprecht C. Bickel, et al. 2008 Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome Eur J Cardiovasc Prev Rehabil 15 278 284 10.1097/HJR.0b013e3282f37a6e 18525381
    • (2008) Eur J Cardiovasc Prev Rehabil , vol.15 , pp. 278-284
    • Espinola-Klein, C.1    Rupprecht, H.J.2    Bickel, C.3
  • 15
    • 64749093076 scopus 로고    scopus 로고
    • Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: Synergistic effect of inflammation and hyperglycemia
    • 10.2337/dc08-1710 19092166
    • M. Trøseid I. Seljeflot E.M. Hjerkinn H. Arnesen 2009 Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia Diabetes Care 32 486 492 10.2337/dc08-1710 19092166
    • (2009) Diabetes Care , vol.32 , pp. 486-492
    • Trøseid, M.1    Seljeflot, I.2    Hjerkinn, E.M.3    Arnesen, H.4
  • 16
    • 66349123572 scopus 로고    scopus 로고
    • Myeloperoxidase, modified lipoproteins, and atherogenesis
    • 10.1194/jlr.R800086-JLR200 19091698
    • S.J. Nicholls S.L. Hazen 2009 Myeloperoxidase, modified lipoproteins, and atherogenesis J Lipid Res 50 Suppl S346 S351 10.1194/jlr.R800086-JLR200 19091698
    • (2009) J Lipid Res , vol.50 , Issue.SUPPL
    • Nicholls, S.J.1    Hazen, S.L.2
  • 17
    • 67449123456 scopus 로고    scopus 로고
    • HDL, lipid peroxidation, and atherosclerosis
    • 10.1194/jlr.E900001-JLR200 1:CAS:528:DC%2BD1MXks1WisLY%3D 19141435
    • B. Shao J.W. Heinecke 2009 HDL, lipid peroxidation, and atherosclerosis J Lipid Res 50 599 601 10.1194/jlr.E900001-JLR200 1:CAS:528:DC%2BD1MXks1WisLY%3D 19141435
    • (2009) J Lipid Res , vol.50 , pp. 599-601
    • Shao, B.1    Heinecke, J.W.2
  • 19
    • 43849102348 scopus 로고    scopus 로고
    • Myeloperoxidase: A new biomarker of inflammation in ischemic heart disease and acute coronary syndromes
    • DOI 10.1155/2008/135625
    • V. Loria I. Dato F. Graziani L.M. Biasucci 2008 Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes Mediators Inflamm 2008 135625 10.1155/2008/135625 18382609 (Pubitemid 351697086)
    • (2008) Mediators of Inflammation , vol.2008 , pp. 135625
    • Loria, V.1    Dato, I.2    Graziani, F.3    Biasucci, L.M.4
  • 20
    • 67650214712 scopus 로고    scopus 로고
    • Determination of myeloperoxidase in EDTA plasma: Comparison of an enzyme-linked immunosorbent assay with a chemiluminescent automated immunoassay
    • 10.1016/j.cca.2009.05.009 1:CAS:528:DC%2BD1MXoslCqtr4%3D 19463803
    • S. Zelzer G. Khoschsorur M. Stettin, et al. 2009 Determination of myeloperoxidase in EDTA plasma: comparison of an enzyme-linked immunosorbent assay with a chemiluminescent automated immunoassay Clin Chim Acta 406 62 65 10.1016/j.cca.2009.05.009 1:CAS:528:DC%2BD1MXoslCqtr4%3D 19463803
    • (2009) Clin Chim Acta , vol.406 , pp. 62-65
    • Zelzer, S.1    Khoschsorur, G.2    Stettin, M.3
  • 22
    • 51449084637 scopus 로고    scopus 로고
    • Flavonoids as substrates and inhibitors of myeloperoxidase: Molecular actions of aglycone and metabolites
    • 10.1021/tx8000835 1:CAS:528:DC%2BD1cXosVejs7Y%3D 18620432
    • Y. Shiba T. Kinoshita H. Chuman, et al. 2008 Flavonoids as substrates and inhibitors of myeloperoxidase: molecular actions of aglycone and metabolites Chem Res Toxicol 21 1600 1609 10.1021/tx8000835 1:CAS:528:DC%2BD1cXosVejs7Y%3D 18620432
    • (2008) Chem Res Toxicol , vol.21 , pp. 1600-1609
    • Shiba, Y.1    Kinoshita, T.2    Chuman, H.3
  • 23
    • 34247142940 scopus 로고    scopus 로고
    • Use of BNP and CRP as biomarkers in assessing cardiovascular disease: Diagnosis versus risk
    • 10.2174/157016107779317251 1:CAS:528:DC%2BD2sXitlamsLc%3D 17266610
    • V.M. Miller M.M. Redfield J.P. McConnell 2007 Use of BNP and CRP as biomarkers in assessing cardiovascular disease: diagnosis versus risk Curr Vasc Pharmacol 5 15 25 10.2174/157016107779317251 1:CAS:528:DC%2BD2sXitlamsLc%3D 17266610
    • (2007) Curr Vasc Pharmacol , vol.5 , pp. 15-25
    • Miller, V.M.1    Redfield, M.M.2    McConnell, J.P.3
  • 24
    • 41349087144 scopus 로고    scopus 로고
    • B-type natriuretic peptide (BNP) and proBNP: Role of emerging markers to guide therapy and determine prognosis in cardiovascular disorders
    • 10.1097/MJT.0b013e31815af96f 18356635
    • D. Godkar K. Bachu B. Dave, et al. 2008 B-type natriuretic peptide (BNP) and proBNP: role of emerging markers to guide therapy and determine prognosis in cardiovascular disorders Am J Ther 15 150 156 10.1097/MJT.0b013e31815af96f 18356635
    • (2008) Am J Ther , vol.15 , pp. 150-156
    • Godkar, D.1    Bachu, K.2    Dave, B.3
  • 25
    • 66349111768 scopus 로고    scopus 로고
    • B-type natriuretic peptide: A strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department
    • 10.1097/MCA.0b013e3283292ac6 19293713
    • R. Bassan B.R. Tura A.S. Maisel 2009 B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department Coron Artery Dis 20 143 149 10.1097/MCA.0b013e3283292ac6 19293713
    • (2009) Coron Artery Dis , vol.20 , pp. 143-149
    • Bassan, R.1    Tura, B.R.2    Maisel, A.S.3
  • 26
    • 66349102004 scopus 로고    scopus 로고
    • Incremental value of high-sensitivity C-reactive protein and N-terminal pro-Btype natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients
    • 10.1097/MCA.0b013e3283219e47 19322079
    • D. Goei S.E. Hoeks E. Boersma, et al. 2009 Incremental value of high-sensitivity C-reactive protein and N-terminal pro-Btype natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients Coron Artery Dis 20 219 224 10.1097/MCA.0b013e3283219e47 19322079
    • (2009) Coron Artery Dis , vol.20 , pp. 219-224
    • Goei, D.1    Hoeks, S.E.2    Boersma, E.3
  • 28
    • 33747079319 scopus 로고    scopus 로고
    • Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study
    • DOI 10.1161/CIRCULATIONAHA.105.590927, PII 0000301720060718000007
    • S. Blankenberg M.J. McQueen M. Smieja, et al. 2006 Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study Circulation 114 201 208 10.1161/CIRCULATIONAHA.105.590927 1:CAS:528:DC%2BD28Xms1yrtLo%3D 16831981 (Pubitemid 44297113)
    • (2006) Circulation , vol.114 , Issue.3 , pp. 201-208
    • Blankenberg, S.1    McQueen, M.J.2    Smieja, M.3    Pogue, J.4    Balion, C.5    Lonn, E.6    Rupprecht, H.J.7    Bickel, C.8    Tiret, L.9    Cambien, F.10    Gerstein, H.11    Munzel, T.12    Yusuf, S.13
  • 29
    • 58549118043 scopus 로고    scopus 로고
    • Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: The epidemiological evidence
    • 10.1007/s10557-008-6135-6 1:CAS:528:DC%2BD1MXotVyrug%3D%3D 18949547
    • W. Koenig N. Khuseyinova 2009 Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: the epidemiological evidence Cardiovasc Drugs Ther 23 85 92 10.1007/s10557-008-6135-6 1:CAS:528: DC%2BD1MXotVyrug%3D%3D 18949547
    • (2009) Cardiovasc Drugs Ther , vol.23 , pp. 85-92
    • Koenig, W.1    Khuseyinova, N.2
  • 30
    • 51749105639 scopus 로고    scopus 로고
    • Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker
    • 10.1016/j.amjcard.2008.04.018 1:CAS:528:DC%2BD1cXosVantr8%3D 18549871
    • M.A. Corson P.H. Jones M.H. Davidson 2008 Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker Am J Cardiol 101 41F 50F 10.1016/j.amjcard.2008.04.018 1:CAS:528:DC%2BD1cXosVantr8%3D 18549871
    • (2008) Am J Cardiol , vol.101
    • Corson, M.A.1    Jones, P.H.2    Davidson, M.H.3
  • 31
    • 60249094866 scopus 로고    scopus 로고
    • Use of biomarkers to develop treatment strategies for atherosclerosis
    • 18647586
    • M.A. Crandall M.A. Corson 2008 Use of biomarkers to develop treatment strategies for atherosclerosis Curr Treat Options Cardiovasc Med 10 304 315 18647586
    • (2008) Curr Treat Options Cardiovasc Med , vol.10 , pp. 304-315
    • Crandall, M.A.1    Corson, M.A.2
  • 32
    • 34249701265 scopus 로고    scopus 로고
    • Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: Association with early coronary atherosclerosis and endothelial dysfunction in humans
    • DOI 10.1161/CIRCULATIONAHA.106.671420
    • 2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans Circulation 115 2715 2721 10.1161/CIRCULATIONAHA.106.671420 1:CAS:528:DC%2BD2sXlsVOns7Y%3D 17502572 (Pubitemid 46842787)
    • (2007) Circulation , vol.115 , Issue.21 , pp. 2715-2721
    • Lavi, S.1    McConnell, J.P.2    Rihal, C.S.3    Prasad, A.4    Mathew, V.5    Lerman, L.O.6    Lerman, A.7
  • 33
    • 44449157784 scopus 로고    scopus 로고
    • Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques
    • 10.1161/STROKEAHA.107.503193 1:CAS:528:DC%2BD1cXkvVeitr0%3D 18356547
    • D. Mannheim J. Herrmann D. Versari, et al. 2008 Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques Stroke 39 1448 1455 10.1161/STROKEAHA.107.503193 1:CAS:528: DC%2BD1cXkvVeitr0%3D 18356547
    • (2008) Stroke , vol.39 , pp. 1448-1455
    • Mannheim, D.1    Herrmann, J.2    Versari, D.3
  • 34
    • 60249101701 scopus 로고    scopus 로고
    • Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): A phase II double-blind, randomised, placebo-controlled trial
    • 10.1016/S0140-6736(09)60403-7 1:CAS:528:DC%2BD1MXitFyrsLc%3D 19231633
    • R.S. Rosenson C. Hislop D. McConnell, et al. 2009 Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial Lancet 373 649 658 10.1016/S0140-6736(09)60403-7 1:CAS:528:DC%2BD1MXitFyrsLc%3D 19231633
    • (2009) Lancet , vol.373 , pp. 649-658
    • Rosenson, R.S.1    Hislop, C.2    McConnell, D.3
  • 35
    • 53549093853 scopus 로고    scopus 로고
    • Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
    • 10.1038/nm.1870 1:CAS:528:DC%2BD1cXht1Slu7rE 18806801
    • R.L. Wilensky Y. Shi E.R. Mohler 3rd, et al. 2008 Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development Nat Med 14 1059 1066 10.1038/nm.1870 1:CAS:528: DC%2BD1cXht1Slu7rE 18806801
    • (2008) Nat Med , vol.14 , pp. 1059-1066
    • Wilensky, R.L.1    Shi, Y.2    Mohler III, E.R.3
  • 36
    • 54049152760 scopus 로고    scopus 로고
    • Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque
    • 10.1161/CIRCULATIONAHA.108.771899 1:CAS:528:DC%2BD1cXhtVOiurjK 18765397
    • P.W. Serruys H.M. García-García P. Buszman, et al. 2008 Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque Circulation 118 1172 1182 10.1161/CIRCULATIONAHA.108.771899 1:CAS:528:DC%2BD1cXhtVOiurjK 18765397
    • (2008) Circulation , vol.118 , pp. 1172-1182
    • Serruys, P.W.1    García-García, H.M.2    Buszman, P.3
  • 37
    • 49449096539 scopus 로고    scopus 로고
    • Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2
    • 10.1021/jm800422v 1:CAS:528:DC%2BD1cXot1ahtbs%3D 18605714
    • R.C. Oslund N. Cermak M.H. Gelb 2008 Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2 J Med Chem 51 4708 4714 10.1021/jm800422v 1:CAS:528:DC%2BD1cXot1ahtbs%3D 18605714
    • (2008) J Med Chem , vol.51 , pp. 4708-4714
    • Oslund, R.C.1    Cermak, N.2    Gelb, M.H.3
  • 38
    • 44449119583 scopus 로고    scopus 로고
    • Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein
    • 10.1074/jbc.M709970200 1:CAS:528:DC%2BD1cXisFOktrw%3D 18165686
    • B. Davis G. Koster L.J. Douet, et al. 2008 Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein J Biol Chem 283 6428 6437 10.1074/jbc.M709970200 1:CAS:528:DC%2BD1cXisFOktrw%3D 18165686
    • (2008) J Biol Chem , vol.283 , pp. 6428-6437
    • Davis, B.1    Koster, G.2    Douet, L.J.3
  • 39
    • 43449090390 scopus 로고    scopus 로고
    • Variability of lipoprotein-associated phospholipase A2 measurements
    • DOI 10.1373/clinchem.2008.103358
    • J.P. McConnell A.S. Jaffe 2008 Variability of lipoprotein-associated phospholipase A2 measurements Clin Chem 54 932 933 10.1373/clinchem.2008.103358 1:CAS:528:DC%2BD1cXlsVWju7k%3D 18443185 (Pubitemid 351671617)
    • (2008) Clinical Chemistry , vol.54 , Issue.5 , pp. 932-933
    • McConnell, J.P.1    Jaffe, A.S.2
  • 40
    • 55249087635 scopus 로고    scopus 로고
    • Genetically elevated C-reactive protein and ischemic vascular disease
    • 10.1056/NEJMoa0707402 1:CAS:528:DC%2BD1cXhtlaitbbE 18971492
    • J. Zacho A. Tybjaerg-Hansen J.S. Jensen, et al. 2008 Genetically elevated C-reactive protein and ischemic vascular disease N Engl J Med 359 1897 1908 10.1056/NEJMoa0707402 1:CAS:528:DC%2BD1cXhtlaitbbE 18971492
    • (2008) N Engl J Med , vol.359 , pp. 1897-1908
    • Zacho, J.1    Tybjaerg-Hansen, A.2    Jensen, J.S.3
  • 41
    • 51649092992 scopus 로고    scopus 로고
    • C-reactive protein and coronary heart disease: A critical review
    • 10.1111/j.1365-2796.2008.02015.x 1:CAS:528:DC%2BD1cXht1Omt7%2FJ 18823504
    • J.P. Casas T. Shah A.D. Hingorani, et al. 2008 C-reactive protein and coronary heart disease: a critical review J Intern Med 264 295 314 10.1111/j.1365-2796.2008.02015.x 1:CAS:528:DC%2BD1cXht1Omt7%2FJ 18823504
    • (2008) J Intern Med , vol.264 , pp. 295-314
    • Casas, J.P.1    Shah, T.2    Hingorani, A.D.3
  • 42
    • 59649124121 scopus 로고    scopus 로고
    • Determinants of the acute-phase protein C-reactive protein in myocardial infarction survivors: The role of comorbidities and environmental factors
    • 10.1373/clinchem.2008.112334 19095729
    • R. Rückerl A. Peters N. Khuseyinova, et al. 2009 Determinants of the acute-phase protein C-reactive protein in myocardial infarction survivors: the role of comorbidities and environmental factors Clin Chem 55 322 335 10.1373/clinchem.2008.112334 19095729
    • (2009) Clin Chem , vol.55 , pp. 322-335
    • Rückerl, R.1    Peters, A.2    Khuseyinova, N.3
  • 43
    • 59649099505 scopus 로고    scopus 로고
    • The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines
    • 10.1373/clinchem.2008.109728 1:CAS:528:DC%2BD1MXhvVWksrc%3D 19095730
    • S. Mora K. Musunuru R.S. Blumenthal 2009 The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines Clin Chem 55 219 228 10.1373/clinchem.2008.109728 1:CAS:528:DC%2BD1MXhvVWksrc%3D 19095730
    • (2009) Clin Chem , vol.55 , pp. 219-228
    • Mora, S.1    Musunuru, K.2    Blumenthal, R.S.3
  • 44
    • 56749106312 scopus 로고    scopus 로고
    • Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
    • 10.1056/NEJMoa0807646 1:CAS:528:DC%2BD1cXhtl2gurnL 18997196
    • P.M. Ridker E. Danielson F.A. Fonseca, et al. 2008 Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2195 2207 10.1056/NEJMoa0807646 1:CAS:528:DC%2BD1cXhtl2gurnL 18997196
    • (2008) N Engl J Med , vol.359 , pp. 2195-2207
    • Ridker, P.M.1    Danielson, E.2    Fonseca, F.A.3
  • 45
    • 63649095045 scopus 로고    scopus 로고
    • Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the JUPITER trial
    • 10.1016/S0140-6736(09)60447-5 1:CAS:528:DC%2BD1MXktV2gsL8%3D 19329177
    • P.M. Ridker E. Danielson F.A. Fonseca, et al. 2009 Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial Lancet 373 1175 1182 10.1016/S0140-6736(09)60447-5 1:CAS:528:DC%2BD1MXktV2gsL8%3D 19329177
    • (2009) Lancet , vol.373 , pp. 1175-1182
    • Ridker, P.M.1    Danielson, E.2    Fonseca, F.A.3
  • 46
    • 61549111294 scopus 로고    scopus 로고
    • Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: Implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study
    • 10.1016/j.jacc.2008.12.010 1:CAS:528:DC%2BD1MXjtFOjsLs%3D 19281922
    • E.D. Michos R.S. Blumenthal 2009 Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study J Am Coll Cardiol 53 931 935 10.1016/j.jacc.2008.12.010 1:CAS:528: DC%2BD1MXjtFOjsLs%3D 19281922
    • (2009) J Am Coll Cardiol , vol.53 , pp. 931-935
    • Michos, E.D.1    Blumenthal, R.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.